...
首页> 外文期刊>Trials >Prevention of severe infectious complications after colorectal surgery using preoperative orally administered antibiotic prophylaxis (PreCaution): study protocol for a randomized controlled trial
【24h】

Prevention of severe infectious complications after colorectal surgery using preoperative orally administered antibiotic prophylaxis (PreCaution): study protocol for a randomized controlled trial

机译:术前口服抗生素预防结直肠癌术后严重感染并发症的预防(预防措施):一项随机对照试验的研究方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Colorectal surgery is frequently complicated by surgical site infections (SSIs). The most important consequences of SSIs are prolonged hospitalization, an increased risk of surgical reintervention and an increase in mortality. Perioperative intravenously administered antibiotic prophylaxis is the standard of care to reduce the risk of SSIs. In the last few decades, preoperative orally administered antibiotics have been suggested as additional prophylaxis to further reduce the risk of infection, but are currently not part of routine practice in most hospitals. The objective of this study is to evaluate the efficacy of a preoperative orally administered antibiotic prophylaxis (Pre-OP) in addition to intravenously administered perioperative antibiotic prophylaxis to reduce the incidence of deep SSIs and/or mortality after elective colorectal surgery. The PreCaution trial is designed as a multicenter, double-blind, randomized, placebo-controlled clinical trial that will be carried out in The Netherlands. Adult patients who are scheduled for elective colorectal surgery are eligible to participate. In total, 966 patients will be randomized to receive the study medication. This will either be Pre-OP, a solution that consists of tobramycin and colistin sulphate, or a placebo solution. The study medication will be administered four times daily during the 3?days prior to surgery. Perioperative intravenously administered antibiotic prophylaxis will be administered to all patients in accordance with national infection control guidelines. The primary endpoint of the study is the cumulative incidence of deep SSIs and/or mortality within 30?days after surgery. Secondary endpoints include both infectious and non-infectious complications of colorectal surgery, and will be evaluated 30?days and/or 6?months after surgery. To date, conclusive evidence on the added value of preoperative orally administered antibiotic prophylaxis in colorectal surgery is lacking. The PreCaution trial should determine the effects of orally administered antibiotics in preventing infectious complications in elective colorectal surgery. Netherlands Trial Register, ID: NTR6113 . Registered on 11 October 2016; EudraCT 2015-005736-17.
机译:大肠手术通常会因手术部位感染(SSI)而变得复杂。 SSI的最重要后果是住院时间延长,手术再次干预的风险增加以及死亡率增加。围手术期静脉内给予抗生素预防是降低SSI风险的护理标准。在过去的几十年中,术前口服抗生素已被建议作为进一步预防感染的方法,以进一步降低感染的风险,但目前在大多数医院中,这并不是常规做法的一部分。这项研究的目的是评估术前口服抗生素预防(Pre-OP)的效果,以及静脉内围手术期抗生素预防的效果,以减少选择性结直肠手术后深SSI的发生率和/或死亡率。 PreCaution试验被设计为将在荷兰进行的多中心,双盲,随机,安慰剂对照的临床试验。计划进行选择性结直肠手术的成年患者有资格参加。总共966名患者将被随机分配接受研究药物。这将是Pre-OP(由妥布霉素和硫酸粘菌素组成的溶液)或安慰剂溶液。研究药物将在手术前3天内每天四次给药。将根据国家感染控制指南对所有患者进行围手术期静脉内给予的抗生素预防。该研究的主要终点是术后30天内深层SSI的累积发生率和/或死亡率。次要终点包括结直肠手术的感染性和非感染性并发症,将在术后30天和/或6个月进行评估。迄今为止,缺乏结直肠手术前口服抗生素预防性预防的附加价值的确凿证据。 PreCaution试验应确定口服抗生素在预防结直肠癌手术中预防感染并发症的作用。荷兰审判注册,ID:NTR6113。 2016年10月11日注册; EudraCT 2015-005736-17。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号